摘要
目的回顾性分析了本院自1978~1995年收治的12例Ⅰ~Ⅱ期喉恶性淋巴瘤的治疗情况。方法全部病例均予局部放射治疗和全身化疗,放疗剂量45~72Gy(中位57Gy),联合化疗方案包括COP、COF、CHOP(1~6疗程)。结果一、三、五年生存率分别为83.3%、57.1%、45.7%(寿命表法)。2例治疗后半年内死于胃肠道淋巴瘤,1例治疗后5年出现扁桃体淋巴瘤。结论放疗和化疗的联合治疗对Ⅰ~Ⅱ期喉恶性淋巴瘤的预后较好。
PURPOSE 12 patients with stage Ⅰ Ⅱ primary non Hodgkins lymphoma of larynx are reviewed in this study.METHODS All patients,who were treated at the Cancer Hospital of Shanghai Medical University between 1978 and 1995,underwent external beam irradiation and adjuvant chemotherapy,the dose ranged from 45 72 Gy(median,57 Gy),the combination chemotherapy schedules included COP,COF,CHOP (1~6 courses).RESULTS The overall 1,3,5 year survival rates were 83 3%,57 1% and 45 7% respectively.Two patients died of gastrointestinal lymphoma six months after treatment.A tonsillar lymphoma was found in another patient five years after treatment.CONCLUSION Combined external beam irradiation and chemotherapy may lead to favorable prognosis of laryngeal stage ⅠandⅡnon Hodgkins lymphoma,but the optimum regimen needs further investigation.
出处
《中国癌症杂志》
CAS
CSCD
1998年第2期135-136,共2页
China Oncology
关键词
非何杰淋巴瘤
治疗
喉肿瘤
Larynx Non Hodgkin′s lymphoma Treatment